205 related articles for article (PubMed ID: 32083003)
21. Magnetic resonance imaging preprocessing and radiomic features for classification of autosomal dominant polycystic kidney disease genotype.
Kremer LE; Chapman AB; Armato SG
J Med Imaging (Bellingham); 2023 Nov; 10(6):064503. PubMed ID: 38156331
[TBL] [Abstract][Full Text] [Related]
22. Radiomics Signature as a Predictive Factor for EGFR Mutations in Advanced Lung Adenocarcinoma.
Hong D; Xu K; Zhang L; Wan X; Guo Y
Front Oncol; 2020; 10():28. PubMed ID: 32082997
[No Abstract] [Full Text] [Related]
23. Serial T2-Weighted Magnetic Resonance Images Acquired on a 1.5 Tesla Magnetic Resonance Linear Accelerator Reveal Radiomic Feature Variation in Organs at Risk: An Exploratory Analysis of Novel Metrics of Tissue Response in Prostate Cancer.
Lorenz JW; Schott D; Rein L; Mostafaei F; Noid G; Lawton C; Bedi M; Li XA; Schultz CJ; Paulson E; Hall WA
Cureus; 2019 Apr; 11(4):e4510. PubMed ID: 31259119
[TBL] [Abstract][Full Text] [Related]
24. CT-Imaging Based Analysis of Invasive Lung Adenocarcinoma Presenting as Ground Glass Nodules Using Peri- and Intra-nodular Radiomic Features.
Wu L; Gao C; Xiang P; Zheng S; Pang P; Xu M
Front Oncol; 2020; 10():838. PubMed ID: 32537436
[No Abstract] [Full Text] [Related]
25. Radiomics Analysis and Correlation With Metabolic Parameters in Nasopharyngeal Carcinoma Based on PET/MR Imaging.
Feng Q; Liang J; Wang L; Niu J; Ge X; Pang P; Ding Z
Front Oncol; 2020; 10():1619. PubMed ID: 33014815
[No Abstract] [Full Text] [Related]
26. Reproducibility Analysis of Radiomic Features from T2-weighted MRI after Processing and Segmentation Alternations in Neuroblastoma Tumors.
Veiga-Canuto D; Fernández-Patón M; Cerdà Alberich L; Jiménez Pastor A; Gomis Maya A; Carot Sierra JM; Sangüesa Nebot C; Martínez de Las Heras B; Pötschger U; Taschner-Mandl S; Neri E; Cañete A; Ladenstein R; Hero B; Alberich-Bayarri Á; Martí-Bonmatí L
Radiol Artif Intell; 2024 Jun; ():e230208. PubMed ID: 38864742
[No Abstract] [Full Text] [Related]
27. Prediction of pathological nodal involvement by CT-based Radiomic features of the primary tumor in patients with clinically node-negative peripheral lung adenocarcinomas.
Liu Y; Kim J; Balagurunathan Y; Hawkins S; Stringfield O; Schabath MB; Li Q; Qu F; Liu S; Garcia AL; Ye Z; Gillies RJ
Med Phys; 2018 Jun; 45(6):2518-2526. PubMed ID: 29624702
[TBL] [Abstract][Full Text] [Related]
28. Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
Zhou X; Yi Y; Liu Z; Cao W; Lai B; Sun K; Li L; Zhou Z; Feng Y; Tian J
Ann Surg Oncol; 2019 Jun; 26(6):1676-1684. PubMed ID: 30887373
[TBL] [Abstract][Full Text] [Related]
29. A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images.
Zhang Z; Yang J; Ho A; Jiang W; Logan J; Wang X; Brown PD; McGovern SL; Guha-Thakurta N; Ferguson SD; Fave X; Zhang L; Mackin D; Court LE; Li J
Eur Radiol; 2018 Jun; 28(6):2255-2263. PubMed ID: 29178031
[TBL] [Abstract][Full Text] [Related]
30. Integration of dynamic contrast-enhanced magnetic resonance imaging and T2-weighted imaging radiomic features by a canonical correlation analysis-based feature fusion method to predict histological grade in ductal breast carcinoma.
Fan M; Liu Z; Xie S; Xu M; Wang S; Gao X; Li L
Phys Med Biol; 2019 Oct; 64(21):215001. PubMed ID: 31470420
[TBL] [Abstract][Full Text] [Related]
31. Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer.
Abdollahi H; Mofid B; Shiri I; Razzaghdoust A; Saadipoor A; Mahdavi A; Galandooz HM; Mahdavi SR
Radiol Med; 2019 Jun; 124(6):555-567. PubMed ID: 30607868
[TBL] [Abstract][Full Text] [Related]
32. Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery.
Kirienko M; Cozzi L; Antunovic L; Lozza L; Fogliata A; Voulaz E; Rossi A; Chiti A; Sollini M
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):207-217. PubMed ID: 28944403
[TBL] [Abstract][Full Text] [Related]
33. Radiomic signature as a predictive factor for lymph node metastasis in early-stage cervical cancer.
Kan Y; Dong D; Zhang Y; Jiang W; Zhao N; Han L; Fang M; Zang Y; Hu C; Tian J; Li C; Luo Y
J Magn Reson Imaging; 2019 Jan; 49(1):304-310. PubMed ID: 30102438
[TBL] [Abstract][Full Text] [Related]
34. Discrimination of mediastinal metastatic lymph nodes in NSCLC based on radiomic features in different phases of CT imaging.
Sha X; Gong G; Qiu Q; Duan J; Li D; Yin Y
BMC Med Imaging; 2020 Feb; 20(1):12. PubMed ID: 32024469
[TBL] [Abstract][Full Text] [Related]
35. Whole-body 3D T1-weighted MR imaging in patients with prostate cancer: feasibility and evaluation in screening for metastatic disease.
Pasoglou V; Michoux N; Peeters F; Larbi A; Tombal B; Selleslagh T; Omoumi P; Vande Berg BC; Lecouvet FE
Radiology; 2015 Apr; 275(1):155-66. PubMed ID: 25513855
[TBL] [Abstract][Full Text] [Related]
36. Exploratory Study to Identify Radiomics Classifiers for Lung Cancer Histology.
Wu W; Parmar C; Grossmann P; Quackenbush J; Lambin P; Bussink J; Mak R; Aerts HJ
Front Oncol; 2016; 6():71. PubMed ID: 27064691
[TBL] [Abstract][Full Text] [Related]
37. A radiomics pipeline dedicated to Breast MRI: validation on a multi-scanner phantom study.
Saint Martin MJ; Orlhac F; Akl P; Khalid F; Nioche C; Buvat I; Malhaire C; Frouin F
MAGMA; 2021 Jun; 34(3):355-366. PubMed ID: 33180226
[TBL] [Abstract][Full Text] [Related]
38. Vulnerabilities of radiomic signature development: The need for safeguards.
Welch ML; McIntosh C; Haibe-Kains B; Milosevic MF; Wee L; Dekker A; Huang SH; Purdie TG; O'Sullivan B; Aerts HJWL; Jaffray DA
Radiother Oncol; 2019 Jan; 130():2-9. PubMed ID: 30416044
[TBL] [Abstract][Full Text] [Related]
39. Extraction of radiomic values from lung adenocarcinoma with near-pure subtypes in the International Association for the Study of Lung Cancer/the American Thoracic Society/the European Respiratory Society (IASLC/ATS/ERS) classification.
Yang SM; Chen LW; Wang HJ; Chen LR; Lor KL; Chen YC; Lin MW; Hsieh MS; Chen JS; Chang YC; Chen CM
Lung Cancer; 2018 May; 119():56-63. PubMed ID: 29656753
[TBL] [Abstract][Full Text] [Related]
40. Identifying Cross-Scale Associations between Radiomic and Pathomic Signatures of Non-Small Cell Lung Cancer Subtypes: Preliminary Results.
Alvarez-Jimenez C; Sandino AA; Prasanna P; Gupta A; Viswanath SE; Romero E
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33297357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
